Search for: "TEVA PHARMACEUTICAL INDUSTRIES LTD" Results 41 - 60 of 258
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Mar 2017, 4:00 am by Berniard Law Firm
In 2010, the Whiteners sued PLIVA, Inc., Barr Laboratories, Inc., Teva Pharmaceutical Industries, Ltd., Alaven Pharmaceutical L.L.C., Meda Pharmaceuticals, Inc., and Schwarz Pharma, Inc. [read post]
6 Mar 2017, 9:00 am by Brianna Smith
From Mylan and their Epipen fiasco to Teva Pharmaceutical Industries Ltd, consumers are wondering when someone will step in to make this price gouging stop before drugs like the Epipen simply become unaffordable. [read post]
25 Jan 2017, 11:25 pm
However, claim 27 is to “a pharmaceutical composition comprising a compound according to any one of claims 1-25 together with a pharmaceutically acceptable carrier and optionally other therapeutic ingredients” (emphasis added). [read post]
18 Jan 2017, 1:28 pm
 Staying with patents, as IPKat member Neil Wilkof discusses on IP Finance the challenges faced by the world’s largest generic drug company, Teva Pharmaceutical Industries Ltd (based in Israel), but whose most successful product in recent years has been the proprietary drug COPAXONE. [read post]
16 Jan 2017, 5:44 pm by Dennis Crouch
Teva Pharmaceuticals USA, Inc., et al. [read post]
12 Jan 2017, 11:11 am by Neil Wilkof
There is no pharmaceutical company that better reflects the challenges of trying to master both these product markets than the Israeli-based company, Teva Pharmaceutical Industries Ltd. [read post]
9 Jan 2017, 9:36 am by Lawrence B. Ebert
In other words, Copaxone should remain a $4 billion drug, to Pantagraph: covering "three per week" dosing were not at issue in the Supreme Court case of Teva Pharmaceuticals USA, Inc. v. [read post]
30 Dec 2016, 2:58 pm
Permission to appeal in patent cases - farewell to the Pozzoli approachGuest Kat Eibhlin Vardy recaps the case Teva UK Ltd v Boehringer Ingelheim Pharma GmbH & Co KG, [2016] EWCA Civ 1296. [read post]
The world’s largest manufacturer of generic pharmaceuticals, Israeli-based Teva Pharmaceutical Industries Ltd. [read post]
8 Nov 2016, 11:53 pm by Kevin LaCroix
  Next, on November 6, 2016, plaintiffs’ lawyers’ filed a securities class action lawsuit in the Central District of California against Teva Pharmaceuticals Industries Ltd. [read post]
2 Sep 2016, 1:57 pm by John Stigi
  There, plaintiffs brought a putative class action complaint challenging the sale of Auspex Pharmaceuticals, Inc. to Teva Pharmaceuticals Industries, Inc. [read post]
25 Aug 2016, 2:11 pm by Lawrence B. Ebert noted a PTAB ruling on some of Teva's Copaxone patents:Teva Pharmaceutical Industries Ltd. today [August 24, 2016] confirmed the Patent Trial and Appeal Board (PTAB) decisions from an Inter Partes Review (IPR) to invalidate all claims of the ‘250 and ‘413 patents for 40 mg COPAXONE® (glatiramer acetate injection). [read post]
24 Apr 2016, 9:02 pm by Patent Docs
Biocon Ltd. et al. 1:16-cv-00278; filed April 19, 2015 in the District Court of Delaware • Plaintiffs: Teva Pharmaceuticals USA Inc.; Teva Pharmaceutical Industries Ltd.; Teva Neuroscience Inc; Yeda Research and Development Co Ltd. [read post]
17 Mar 2016, 12:12 pm
The allegations of infringement have been directed at Defendants Teva Pharmaceuticals USA, Inc. of North Wales, Pennsylvania and its parent company Teva Pharmaceutical Industries Ltd. of Israel. [read post]